BIFOMED A/S: Financial statements 2020
CVR: 31154774
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BIFOMED A/S (CVR 31154774) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -36,301 and a net result of DKK -55,616 compared with DKK 78,923,605 the year before. Equity in the 2020 report amounted to DKK 13,041,429. The solvency ratio was 99.9%.
- Revenue
- DKK 0
- Gross Profit
- DKK -36,301
- Profit/Loss
- DKK -55,616
- Equity
- DKK 13,041,429
- Total Assets
- DKK 13,052,480
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | -36 t. | -56 t. | 13 mio. | - |
| 2019 | - | -43 t. | 78.9 mio. | 16.1 mio. | - |
| 2018 | - | -10 t. | 2.7 mio. | 14.4 mio. | - |
| 2017 | - | -465 t. | 868 t. | 11.7 mio. | - |
| 2016 | - | -30 t. | 2.3 mio. | 10.9 mio. | - |
Official annual report
How creditworthy is BIFOMED A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BIFOMED A/S has published its annual report for 2019. Gross profit came to DKK -42,797, and the net result was DKK 78,923,605.
About BIFOMED A/S
BIFOMED A/S was a Danish company of the type Aktieselskab based in Hundested, founded in 2007. The company has been dissolved on 3 August 2023. The company was registered under the industry Investeringsselskaber. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -114,334 and a net result of DKK 17,989,340 compared with DKK -55,616 the year before. Equity in the 2021 report amounted to DKK 11,030,769.
